This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Third Look: Discussing the post-surgical setting following orthopedic and soft tissue procedures along with Zynrelef's recent label expansion (January 2024) which will now cover an estimated 13 million procedures annually

Ticker(s): HRTX

Who's the expert?

Institution: Private Practice

  • Clinical Anesthesiology at Private Practice
  • Manages 15 patients monthly with breakthrough postoperative nausea and vomiting and has prescribed the 40 mg oral dose of Aponvie preoperatively

Interview Goal
The focus of this interview will focus on the post-surgical setting following orthopedic and soft tissue procedures along with Zynrelef's recent label expansion (January 2024) which will now cover an estimated 13 million procedures annually

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.